MW 304.3 Da, Purity >99%. Reversible soluble guanylyl cyclase activator (EC₅₀ = 18.6 μM). NO-independent. Induces a concentration dependent increase in cGMP in vitro. Reduces blood-brain barrier permeability through HIF-1 inhibiton in vivo.
The product is subject to the following: Abcam Restricted Use Statement